(Q33382596)
Statements
1 reference
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma (English)
1 reference
Teri N Kreisl
1 reference
Lyndon Kim
1 reference
Kraig Moore
1 reference
Paul Duic
1 reference
Cheryl Royce
1 reference
Irene Stroud
1 reference
Nancy Garren
1 reference
Megan Mackey
1 reference
Kevin Camphausen
1 reference
John Park
1 reference
Paul S Albert
1 reference
Howard A Fine
1 reference
29 December 2008
1 reference
1 reference
27
1 reference
740-745
1 reference
Identifiers
1 reference
1 reference
1 reference